January 22, 2022

Biogen’s Alzheimer’s drug approved in US in treatment landmark, United States News & Top Stories

WASHINGTON (BLOOMBERG) – Biogen received approval for its controversial Alzheimer’s disease therapy, a landmark decision that stands to dramatically change treatment for the debilitating brain condition.

After decades of research failures by numerous companies, Biogen’s aducanumab became the first drug cleared by the US Food and Drug Administration to slow the course of the mind-wasting disease that afflicts 6 million Americans.

The antibody therapy, which will be sold under the name Aduhelm, works by removing amyloid, a harmful protein that clogs the brains of Alzheimer’s patients.

The latest new drug treatment for the disease was first approved in 2003, and existing therapies help with symptoms but don’t alleviate the underlying damage.

The FDA announced the decision in a statement on Monday (June 7).

“In determining that the application met the requirements for accelerated approval, the agency concluded that the benefits of Aduhelm for patients with Alzheimer’s disease outweighed the risks of the therapy,” the agency said.

The approval is one of the more consequential FDA decisions in recent years and likely to be welcome news for millions of Americans with Alzheimer’s disease and their families.

Patient advocacy groups have supported the drug’s clearance despite scepticism from some scientists about its mixed record in clinical trials.

It’s also a significant victory for Cambridge, Massachusetts-based Biogen and its Tokyo-based partner Eisai Co.

Biogen has seen wild swings in its share price with nearly every twist and turn of aducanumab’s development.

Now, it’s on the cusp of rolling out a product that’s widely expected to be a blockbuster, even amid questions about the health-care system’s capacity to cope with demand.

Biogen shares were halted ahead of the news in New York trading and hadn’t yet resumed. US-traded shares of Eisai leapt 56 per cent to US$116 (S$154) at 11.01am in New York.

Scientific controversy

The long-awaited verdict is certain to be scrutinised. Scientists are still furiously debating amyloid’s role in the disease, and aducanumab’s clinical trial results were decidedly mixed.

In one giant trial conducted by Biogen, the drug was ineffective overall. A second, similar study found that high doses of the drug slowed progression of the disease by a modest 22 per cent over 18 months.

For months, scientists and doctors have been bickering about which of the results to believe.

Biogen and proponents of the medicine have argued that one trial succeeded because patients received higher doses than in the study that failed.

Sceptics have said it’s just as likely that the successful trial was a fluke and argued that a third round is needed as a tiebreaker.

Annual sales could peak at US$5 billion, analysts have said, providing a needed financial jolt to Biogen.

Beyond the drug itself, health-care system expenses will include the eligibility tests, infusions and expensive scans to watch for side effects such as brain swelling. It’s unclear whether insurers will readily pay for the drug and all its associated costs.

in World
Related Posts

China’s Xi Jinping to address Glasgow COP26 in written statement, Europe News & Top Stories

November 1, 2021

November 1, 2021

SHANGHAI (REUTERS, XINHUA) – Chinese President Xi Jinping will address the COP26 climate conference in Glasgow on Monday (Nov 1)...

Hospitals in South Africa industrial hub face being overrun by Covid-19 surge, World News & Top Stories

June 26, 2021

June 26, 2021

JOHANNESBURG (BLOOMBERG) – Hospital capacity in South Africa’s industrial hub of Gauteng is at risk of being breached by surging...

US pharmacist jailed for 3 years after tampering with Covid-19 vaccines, United States News & Top Stories

June 9, 2021

June 9, 2021

WASHINGTON (AFP) – A United States pharmacist has been jailed for three years after pleading guilty to tampering with hundreds...

Covid-19 vaccines offer high protection against hospitalisation from Delta variant: UK study, Europe News & Top Stories

June 14, 2021

June 14, 2021

LONDON (REUTERS) – Covid-19 vaccines made by Pfizer and AstraZeneca offer high protection of more than 90 per cent against...

Kremlin says deals at Putin-Biden summit unlikely but talks useful, World News & Top Stories

June 15, 2021

June 15, 2021

MOSCOW (REUTERS) – A meeting between Russian President Vladimir Putin and his United States counterpart Joe Biden in Geneva on...

Biden says he has reached infrastructure deal with bipartisan US senators, United States News & Top Stories

June 24, 2021

June 24, 2021

WASHINGTON (BLOOMBERG) – President Joe Biden said he has reached a tentative deal with a group of Democratic and Republican...

2 top US senators call on Biden to impose sanctions over Hong Kong’s Apple Daily closure, United States News & Top Stories

June 25, 2021

June 25, 2021

WASHINGTON (REUTERS) РTwo leading United States senators have called on President Joe Biden to use powers under a Bill they...

Parched Los Angeles launches fireworks buyback programme ahead of July 4, United States News & Top Stories

June 30, 2021

June 30, 2021

LOS ANGELES (AFP) – The drought-plagued city of Los Angeles announced a fireworks buyback program would be held Wednesday (June...

Car bomb explosion at Colombia military base injures 36, World News & Top Stories

June 16, 2021

June 16, 2021

BOGOTA (REUTERS) – A car bomb explosion at a military base in the Colombian border city of Cucuta injured 36...

Looming US intelligence report to address UFOs, United States News & Top Stories

May 27, 2021

May 27, 2021

WASHINGTON (AFP) – Are aliens watching us? That is what Americans hope to find out when a report on the...

US SEC probing SolarWinds clients over cyber breach disclosures: Sources, United States News & Top Stories

June 21, 2021

June 21, 2021

WASHINGTON (REUTERS) – The US Securities and Exchange Commission (SEC) has opened a probe into last year’s SolarWinds cyber breach,...

‘We are waiting for you’: An agonising vigil for families of Florida collapse victims, United States News & Top Stories

June 30, 2021

June 30, 2021

SURFSIDE, FLORIDA (NYTIMES) – All around Mrs Magaly Ramsey a chorus of newly familiar strangers were shouting out the names...

53% of Republicans view Trump as true US president: Poll, United States News & Top Stories

May 24, 2021

May 24, 2021

WASHINGTON (REUTERS) – A majority of Republicans still believe Mr Donald Trump won the 2020 US presidential election and blame...

EU drug regulator adds another rare blood condition as side effect of AstraZeneca Covid-19 vaccine, Europe News & Top Stories

June 11, 2021

June 11, 2021

FRANKFURT (REUTERS) – Europe’s drug regulator on Friday (June 11) identified another rare blood condition as a potential side effect...

Spain races to vaccinate farm workers against coronavirus ‘time bomb’, Europe News & Top Stories

May 27, 2021

May 27, 2021

ALCARRAS, SPAIN (AFP) – Outside an old blue and white school in northeastern Spain dozens of farm workers wait their...